Sorbitol dehydrogenase (SORD; EC 1.1.1.14) catalyzes the
interconversion of polyols and their corresponding ketoses, and
together with aldose reductase (ALDR1; MIM 103880), makes up the
sorbitol pathway that is believed to play an important role in the
development of diabetic complications (summarized by Carr and
Markham, 1995 [PubMed 8535074]). The first reaction of the pathway
(also called the polyol pathway) is the reduction of glucose to
sorbitol by ALDR1 with NADPH as the cofactor. SORD then oxidizes
the sorbitol to fructose using NAD(+) cofactor.1) Szabo, Z., et al. Oncol. Rep. 23(5):1233-1239(2010)
Immunogen
This SORD antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 211-239 amino acids from the Central region of human SORD.
Western blot analysis in Hela cell line lysates (35ug/lane).
Application Notes
For WB starting dilution is: 1:1000:
Additional Information
Form
Liquid
Storage Instructions
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.